These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32916714)

  • 1. Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing.
    Siamoglou S; Karamperis K; Mitropoulou C; Patrinos GP
    J Appl Lab Med; 2020 Sep; 5(5):1005-1016. PubMed ID: 32916714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Rapid Pharmacogenomic Testing Assay in a Mobile Molecular Biology Laboratory (2MoBiL).
    Psarias G; Iliopoulou E; Liopetas I; Tsironi A; Spanos D; Tsikrika A; Kalafatis K; Tarousi D; Varitis G; Koromina M; Siamoglou S; Patrinos GP
    OMICS; 2020 Nov; 24(11):660-666. PubMed ID: 33064577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of pharmacogenomics into inpatient general medicine.
    Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
    Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
    Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM
    Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.
    Ho TT; Gift M; Alexander E
    Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
    Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
    Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
    [No Abstract]   [Full Text] [Related]  

  • 15. PARC report: a perspective on the state of clinical pharmacogenomics testing.
    Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
    Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders.
    Edris A; Callier E; Lahousse L
    BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial.
    Pierson RC; Gufford BT; Desta Z; Eadon MT
    Pharmacogenomics; 2017 Jun; 18(9):835-841. PubMed ID: 28594278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics: Precision Pharmacy in 503A Compounding.
    Drummond J; Bennet D; Allen LV
    Int J Pharm Compd; 2018; 22(2):95-107. PubMed ID: 29877857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.
    Wu AH; Babic N; Yeo KJ
    Per Med; 2009 May; 6(3):315-327. PubMed ID: 29783510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.